Sharp Packaging Services, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 7451 Keebler Way, Allentown, Pennsylvania (PA) 18106, United States (USA)
- Operations here
- labelmanufacturepackrelabelrepacksterilize
- FDA identifiers
- FEI 3004161147 · DUNS 143696495
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIVaccines and Allergenic Products2026-04-22
- NAIDrug Quality Assurance2025-11-21
- VAIDrug Quality Assurance2022-01-28
- VAIDrug Quality Assurance2019-04-24
- NAIDrug Quality Assurance2018-08-13
- NAIDrug Quality Assurance2017-02-03
- VAIDrug Quality Assurance2014-01-15
- NAIDrug Quality Assurance2011-04-13
Drugs this plant is listed as making
38 distinct drugs across 107 products name this site in their FDA label.
- aripiprazole lauroxilAlkermes, Inc.
- Benzhydrocodone and AcetaminophenZevra Therapeutics, Inc.
- buprenorphine hydrochloride, naloxone hydrochlorideIndivior Inc.
- cemiplimab-rwlcRegeneron Pharmaceuticals, Inc.
- ciprofloxacinBayer HealthCare Pharmaceuticals Inc.
- ciprofloxacin hydrochlorideBayer HealthCare Pharmaceuticals Inc.
- Cyclobenzaprine HydrochlorideAmneal Pharmaceuticals of New York LLC
- darolutamideBayer HealthCare Pharmaceuticals Inc.
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATEPrasco Laboratories
- Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine AspartateTakeda Pharmaceuticals America, Inc.
- Drospirenone and ethinyl estradiolBayer HealthCare Pharmaceuticals Inc.
- Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calciumBayer HealthCare Pharmaceuticals Inc.
- estradiol valerate and estradiol valerate/dienogestBayer HealthCare Pharmaceuticals Inc.
- finerenoneBayer HealthCare Pharmaceuticals Inc.
- gadobutrolBayer HealthCare Pharmaceuticals Inc.
- guanfacineTakeda Pharmaceuticals America, Inc.
- iopromideBayer HealthCare Pharmaceuticals Inc.
- LarotrectinibLoxo Oncology, Inc.
- LevonorgestrelBayer HealthCare Pharmaceuticals Inc.
- lisdexamfetamine dimesylatein shortageTakeda Pharmaceuticals America, Inc.
- MesalamineTakeda Pharmaceuticals America, Inc.
- methotrexatein shortageAntares Pharma, Inc.
- morphine sulfatein shortageNortec Development Associates, Inc.
- Oxycodone HydrochlorideAmneal Pharmaceuticals of New York LLC
- ponatinib hydrochlorideTakeda Pharmaceuticals America, Inc.
- praziquantelBayer HealthCare Pharmaceuticals Inc.
- regorafenibBayer HealthCare Pharmaceuticals Inc.
- RisperidoneIndivior Inc.
- sorafenibBayer HealthCare Pharmaceuticals Inc.
- talazoparibU.S. Pharmaceuticals
- TenapanorArdelyx, Inc.
- TocilizumabBiogen MA Inc
- tolvaptanOtsuka America Pharmaceutical, Inc.
- tucatinibSeagen Inc.
- vepdegestrantArvinas Operations, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.